Randomized Clinical Trial
Copyright ©The Author(s) 2016.
World J Psychiatr. Dec 22, 2016; 6(4): 442-448
Published online Dec 22, 2016. doi: 10.5498/wjp.v6.i4.442
Table 1 Baseline demographics and clinical characteristics n (%)
CharacteristicsRisperidone (n = 43)Olanzapine (n = 42)Quetiapine (n = 42)Ziprasidone (n = 46)All patients (n =173)
Gender
Male34 (79.1)28 (66.7)29 (69.0)29 (63.0)120 (69.4)
Antipsychotic naïve17 (40.5)15 (35.7)21 (50.0)20 (44.4)73 (42.7)
Alcohol last 6 mo
None/no misuse10 (23.3)7 (16.7)7 (16.7)10 (21.7)34 19.7)
Dependency2 (4.7)4 (9.5)6 (14.3)0 (0.0)12 (6.9)
Drugs last 6 mo
None26 (60.5)31 (73.8)30 (71.4)32 (69.6)119 (68.8)
Misuse10 (23.3)6 (14.3)7 (16.7)7 (15.2)30 (17.3)
Diagnosis1n (39)n (42)n (41)n (44)n (166)
Schz and rel.22 (56.4)25 (59.5)25 (61.0)22 (50.0)94 (56.6)
Acute4 (10.3)4 (9.5)2 (4.9)4 (9.1)14 (8.4)
Drug-induced6 (15.4)6 (14.3)5 (12.2)5 (11.4)22 (13.3)
Affective4 10.3)4 (9.5)6 (14.6)5 (11.4)19 (11.4)
Rest3 (7.7)3 (7.1)3 (7.3)8 (18.2)17 (10.2)
Age mean (SD)34.5 (15.6)32.3 (11.2)37.2 (14.8)32.4 (13.5)34.1 (13.9)
QTc admittance mean (SD)422.1 (39.7)420.9 (33.5)421.1 (25.1)420.4 (22.0)421.1 (30.4)
PANSS total mean (SD)73.4 (14.0)76.0 (14.3)73.6 (14.0)70.8 (12.4)73.4 (13.7)
PANSS positive mean (SD)18.6 (4.9)21.3 (4.6)20.0 (3.6)18.8 (3.9)19.7 (7.5)
PANSS negative mean (SD)20.8 (8.1)18.3 (7.3)19.2 (7.1)18.4 (7.4)19.2 (7.5)
PANSS general mean (SD)34.0 (6.5)36.4 (6.6)34.4 (7.6)33.6 (6.3)34.6 (6.8)
CDSS mean (SD)6.8 (4.9)6.3 (4.9)6.4 (4.9)7.8 (6.4)6.9 (5.3)
GAF-F mean (SD)30.8 (5.9)30.1 (6.0)30.6 (7.2)32.2 (5.0)30.9 (6.0)
CGI mean (SD)5.2 (0.6)5.3 (0.7)5.1 (0.7)5.0 (0.6)5.2 (0.6)